AI
MDGL icon

Atria Investments’s Madrigal Pharmaceuticals MDGL Stock Holding History

Atria Investments’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$597K Buy
1,111
+84
+8% +$43K 0.01% 1428
2026
Q1 		$538K Buy
1,027
+39
+4% +$18.6K 0.01% 1412
2025
Q4 		$575K Sell
988
-22
-2% -$11.2K 0.01% 1356
2025
Q3 		$463K Sell
1,010
-136
-12% -$50.7K 0.01% 1462
2025
Q2 		$347K Sell
1,146
-24
-2% -$7.15K ﹤0.01% 1632
2025
Q1 		$388K Buy
1,170
+450
+63% +$148K 0.01% 1484
2024
Q4 		$222K Buy
+720
New +$203K ﹤0.01% 1737
2024
Q3 		– Sell
-893
Closed -$250K – 1995
2024
Q2 		$250K Buy
+893
New +$213K ﹤0.01% 1693

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Atria Investments's MDGL Position: Q2 2026 in Review

Atria Investments increased its Madrigal Pharmaceuticals (MDGL) stake by 8.2% in Q2 2026, buying an estimated $43K and bringing the position to 1,111 shares worth $597K. The position accounts for 0.01% of the portfolio, ranked #1428.

Atria Investments first reported a position in MDGL in Q2 2024 and has held it in 8 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Atria Investments held 1,111 shares of Madrigal Pharmaceuticals worth $597K as of Q2 2026.
  • Atria Investments bought 84 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $43K.
  • Madrigal Pharmaceuticals made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1428 holding.
  • Atria Investments first reported a position in Madrigal Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.